AtriCure, Inc. (ATRC) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, AtriCure reported revenue of $534.5M, up 14.9% from $465.3M the year before. Net income was -$11.4M (a -2.1% net margin), or -$0.24 per diluted share. Gross margin was 75.0% and operating margin was -1.8%. Operating activities generated $57.3M of cash, leaving $48.3M of free cash flow. At fiscal year end, AtriCure held $654.2M in total assets against $162.2M in total liabilities, including $167.4M of cash and equivalents.
Open the full interactive AtriCure financials → Quarterly statements, key ratios, valuation history and price charts.
AtriCure Key Stats
| Share Price | $56.87 |
|---|---|
| Market Cap | $2.78B |
| Revenue YoY Growth | +14.9% |
| 52-Week Range | $25.86 – $60.77 |
| Shares Outstanding | 48.7 million (basic, 2026 Q2) |
AtriCure Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $206.5M | $274.3M | $330.4M | $399.2M | $465.3M | $534.5M |
| Cost of Goods Sold | $655,000 | — | — | — | — | — |
| Gross Profit | $149.3M | $205.9M | $245.9M | $300.4M | $347.5M | $400.8M |
| Operating Income | -$44.2M | $55.2M | -$42.7M | -$26.7M | -$40.0M | -$9.4M |
| Pre-Tax Income | -$48.0M | $50.4M | -$46.2M | -$29.8M | -$43.7M | -$10.2M |
| Income Tax | $114,000 | $188,000 | $268,000 | $591,000 | $1.0M | $1.3M |
| Net Income | -$48.2M | $50.2M | -$46.5M | -$30.4M | -$44.7M | -$11.4M |
| Diluted EPS | -$1.14 | $1.09 | -$1.02 | -$0.66 | -$0.95 | -$0.24 |
AtriCure Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $134.3M | $140.5M | $141.2M | $153.6M |
| Net Income | -$267,000 | $1.8M | $108,000 | $9.0M |
| Diluted EPS | -$0.01 | $0.04 | — | $0.18 |
AtriCure Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41.9M | $43.7M | $58.1M | $84.3M | $122.7M | $167.4M |
| Current Assets | $306.7M | $196.1M | $215.2M | $266.2M | $267.8M | $322.5M |
| Total Assets | $714.5M | $615.3M | $585.4M | $613.9M | $609.3M | $654.2M |
| Current Liabilities | $49.1M | $56.4M | $58.4M | $74.6M | $73.4M | $81.5M |
| Total Long-Term Debt | $60.1M | $60.0M | $60.0M | $63.1M | $64.7M | $61.9M |
| Total Liabilities | $302.1M | $131.6M | $128.7M | $147.8M | $148.4M | $162.2M |
| Shareholders' Equity | $412.4M | $483.8M | $456.8M | $466.2M | $461.0M | $491.9M |
AtriCure Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$19.9M | -$13.8M | -$22.1M | $4.5M | $12.2M | $57.3M |
| Cash From Investing | -$156.2M | $23.5M | $44.0M | $21.8M | $30.2M | -$14.6M |
| Cash From Financing | $189.4M | -$7.6M | -$7.1M | -$32,000 | -$3.6M | $1.2M |
| Free Cash Flow | -$25.1M | -$23.5M | -$39.0M | -$7.5M | $745,000 | $48.3M |
Figures from AtriCure's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full AtriCure financials page for every line item.
AtriCure Company Profile
| Ticker | ATRC |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Mason, Ohio |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001323885 |
Frequently Asked Questions
What was AtriCure's revenue in fiscal 2025?
AtriCure (ATRC) reported revenue of $534.5M for fiscal 2025.
What is AtriCure's annual revenue history?
AtriCure's annual revenue by fiscal year: 2020: $206.5M; 2021: $274.3M; 2022: $330.4M; 2023: $399.2M; 2024: $465.3M; 2025: $534.5M.
What was AtriCure's net income in fiscal 2025?
AtriCure reported net income of -$11.4M for fiscal 2025.
What was AtriCure's earnings per share (EPS) in fiscal 2025?
AtriCure's diluted EPS was -$0.24 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did AtriCure generate in fiscal 2025?
AtriCure generated $48.3M of free cash flow in fiscal 2025.
What was AtriCure's revenue last quarter?
In its most recent reported quarter (2026 Q2), AtriCure reported revenue of $153.6M.
How much debt does AtriCure have?
AtriCure reported $61.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of AtriCure are outstanding?
AtriCure reported a weighted average of 48.7 million basic shares outstanding in 2026 Q2.
What is AtriCure's market cap?
Based on its latest closing price, AtriCure (ATRC) has a market capitalization of about $2.78B.
When does AtriCure's fiscal year end?
AtriCure's fiscal year end, as registered with the SEC, is December 31.
Where is AtriCure headquartered?
AtriCure lists its business address in Mason, Ohio in its SEC filings.
AtriCure Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →